中旗股份：公司在创新药领域的战略并非单纯追求高成本的“全面投入”

Core Viewpoint - The company focuses on the agricultural pesticide sector and emphasizes research and innovation as key drivers for growth, aiming to establish itself as a benchmark enterprise in the life sciences field [1] Summary by Relevant Sections Business Focus - The company is primarily engaged in the pesticide industry and has made long-term investments in innovative research and development, which have formed its core competitive advantage [1] Strategic Investments - The company has invested in various enterprises in the pharmaceutical and veterinary medicine sectors, such as Nanjing Zhongao Translational Medicine Research Institute and Nanjing Paitemei Biotechnology Co., reflecting a multi-faceted strategic approach to drug development [1] Technological Synergy - There is significant technological overlap between pesticides, pharmaceuticals, and veterinary medicines, which supports the company's innovative drug development efforts and enhances its product line and business expansion [1] Sustainable Development - The company's strategy in the innovative drug sector is not solely focused on high-cost investments but is rooted in its core business, aiming for precise breakthroughs and sustainable development through technological collaboration, resource integration, and strategic investments [1]